alpha-cryptoxanthin

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Cai, Hui: 1 article (09/2009)
2.	Cai, Qiuyin: 1 article (09/2009)
3.	Chow, Wong-Ho: 1 article (09/2009)
4.	Dai, Qi: 1 article (09/2009)
5.	Dorjgochoo, Tsogzolmaa: 1 article (09/2009)
6.	Franke, Adrian A: 1 article (09/2009)
7.	Gao, Yu-Tang: 1 article (09/2009)
8.	Li, Honglan: 1 article (09/2009)
9.	Rothman, Nathaniel: 1 article (09/2009)
10.	Shu, Xiao-Ou: 1 article (09/2009)

1.	Disease Progression 01/01/2005 - "These findings suggest that, in these men, higher circulating levels of alpha-cryptoxanthin, alpha-carotene, trans-beta-carotene, and lutein and zeaxanthin may contribute to lower prostate cancer risk but not to disease progression."
2.	Prostatic Neoplasms (Prostate Cancer) 01/01/2005 - "These findings suggest that, in these men, higher circulating levels of alpha-cryptoxanthin, alpha-carotene, trans-beta-carotene, and lutein and zeaxanthin may contribute to lower prostate cancer risk but not to disease progression."
3.	Breast Neoplasms (Breast Cancer) 09/01/2009 - "However, high levels of plasma lycopene other than trans, 5- and 7-cis or trans alpha-cryptoxanthin were inversely associated with the risk of developing breast cancer. "